POZEN Logo
Print Page   Close Window

2004 Press Releases

DATETITLE 
December 21, 2004POZEN's MT 100 To Be Reviewed by Advisory Committee in May 2005Printer Friendly Version
December 08, 2004POZEN Names Dr. William Stagner Senior Vice President, Program Management and Development PlanningPrinter Friendly Version
November 23, 2004GlaxoSmithKline Confirms Strong Pipeline MomentumPrinter Friendly Version
November 23, 2004GlaxoSmithKline Reviews Novel Therapeutics for CNS Disorders and Confirms Strong Pipeline MomentumPrinter Friendly Version
November 03, 2004POZEN To Present at CIBC World Markets Healthcare ConferencePrinter Friendly Version
October 27, 2004POZEN Reports Third Quarter 2004 ResultsPrinter Friendly Version
October 19, 2004POZEN Names Dr. Marshall Reese Executive Vice President, Product DevelopmentPrinter Friendly Version
October 13, 2004POZEN Announces October 27 Webcast of Third Quarter ResultsPrinter Friendly Version
September 20, 2004POZEN To Present at UBS 2004 Global Life Sciences ConferencePrinter Friendly Version
September 08, 2004POZEN to Present at Bear Stearns 17th Annual Healthcare ConferencePrinter Friendly Version
August 03, 2004POZEN Names William L. Hodges CFO and Senior Vice President, Finance & AdministrationPrinter Friendly Version
July 29, 2004POZEN Reports Second Quarter 2004 Results; POZEN Reports Profitability for the First Time in Company HistoryPrinter Friendly Version
July 22, 2004POZEN Announces July 29 Webcast of Second Quarter ResultsPrinter Friendly Version
June 01, 2004POZEN Announces Receipt of Not-Approvable Letter for MT 100Printer Friendly Version
May 20, 2004Arthur S. Kirsch Appointed to POZEN's Board of DirectorsPrinter Friendly Version
May 18, 2004POZEN and GSK Announce Start of Phase III Program for Trexima, a Novel Migraine Treatment; POZEN Will Receive Phase III Initiation Milestone Payment of $15 MillionPrinter Friendly Version
April 29, 2004POZEN Reports First Quarter 2004 ResultsPrinter Friendly Version
April 27, 2004POZEN to Present at the Deutsche Bank Health Care ConferencePrinter Friendly Version
April 22, 2004Pozen Announces April 29 Webcast of First Quarter ResultsPrinter Friendly Version
March 18, 2004POZEN CEO To Present at the Wells Fargo Securities Health Care ConferencePrinter Friendly Version
February 19, 2004POZEN CEO to Present at the 4th Annual Smith Barney Specialty Pharmaceutical ConferencePrinter Friendly Version
February 18, 2004POZEN Reports Fourth Quarter and Full-Year 2003 Results; POZEN Books Revenue and Achieves Positive Cash Flow in 2003Printer Friendly Version
February 12, 2004POZEN Announces February 18 Webcast of Fourth Quarter and Full-Year 2003 ResultsPrinter Friendly Version
January 28, 2004POZEN Announces Favorable Results of Rat Carcinogenicity Study for MT 100 and Submission of Study Report to FDAPrinter Friendly Version
January 27, 2004POZEN To Host January 28 Webcast to Discuss Results of Rat Carcinogenicity Study For MT 100Printer Friendly Version
January 23, 2004POZEN CEO To Present at the U.S. Bancorp Piper Jaffray Health Care ConferencePrinter Friendly Version
January 20, 2004POZEN Announces Resignation of Chief Financial OfficerPrinter Friendly Version